Clinical Trials Logo

Clinical Trial Summary

The principal hypotheses to be tested is that Mindfulness Based Cognitive Therapy (MBCT) reduces the distressing impact of tinnitus to a significantly greater extent than a waiting list control or relaxation therapy.

This study is a mixed design, with two groups assessed at a number of time points. The primary outcome measure will be that of tinnitus distress, and secondary outcomes will be taken of psychological distress and tinnitus loudness.

The outcome measures will be measured first at 8 weeks pre-treatment. All subjects then wait for 8 weeks before being randomly allocated to either an 8 week course of Mindfulness-Based Cognitive Therapy (MBCT) (Group 1) or an 8 week course of Relaxation Therapy (RT) (Group 2). All participants will be assessed at two main time-points (pre and post-treatment). The outcome measures will be repeated at 1 and 6 month follow-up points.


Clinical Trial Description

Experimental design and methods (including statistical analysis)

Participant recruitment:

Potential participants who meet the eligibility criteria will be identified from among patients referred to the adult clinical psychology service within the department of Adult Audiology at the Royal National Throat Nose & Ear Hospital. These patients will be approached and invited to discuss participation in the project. The potential participants will be given full information about the study and invited to consider whether they wish to participate.

Design

This study an independent groups, repeated measures design. Two groups will be assessed at different time points. Group 1 will receive 8 weeks of Mindfulness-Based Cognitive Therapy (MBCT) and Group 2 will receive 8 weeks of Relaxation Training (RT; an active control). All participants will be assessed at five main time-points:

- 8 weeks pre-treatment,

- The start of treatment

- The end of treatment

- 1 month follow-up

- 6 month follow-up

The primary outcome measure will be that of tinnitus complaint, and secondary outcome measures will be taken of psychological distress and tinnitus loudness, tinnitus acceptance and everyday mindfulness.

Measures:

A number of Questionnaire measures and a Visual Analogue Scale will be used to assess tinnitus complaint, psychological well-being and mindfulness.

Participants are evaluated on all measures at initial assessment (8 weeks pre-treatment), at treatment commencement, at end of treatment and at 1and 6 month follow-up.

Statistical Analyses

The primary outcome will be the change in tinnitus complaint as measured by the Tinnitus Questionnaire from pre-treatment to post-treatment. This will be assessed by using t-tests.

Further statistical exploration will use t-tests to assess change from initial assessment to end of the 8-week waiting period, and to assess change or maintenance of change from the end of treatment to the 1and 6 month follow-up points. The same type of analysis will be done on the measures of psychological well-being.

To assess for differences in outcome between the MBCT and RT groups, a series of repeated-measures (2x2) (Group 1 - Group 2 x pre-treatment - post-treatment) ANOVAS will be carried out. This will allow for the assessment of between group effects and any interaction effects between group and time.

A number of correlations will also be performed to assess for relationships between psychological distress pre-treatment and tinnitus outcome within each group. Correlation will also be performed to assess for relationships between changes in tinnitus complaint and tinnitus acceptance and everyday mindfulness. They will also be performed to assess for relationships between changes in psychological distress and everyday mindfulness.

Chi-square analyses will be carried out on the measures of tinnitus complaint and CORE-OM score pre- and post-treatment to assess for the numbers of patients within each group who demonstrate clinically significant change. A clinically significant change in tinnitus complaint is defined as change of at least 10 points reduction on the TQ. A clinically significant change in psychological well-being is defined as a reduction of at least 0.5 on the total mean CORE-OM score.

Correlations will be performed to assess for possible associations between patient characteristics, attendance, amount of home practice and various outcomes. Weekly measures of mindfulness will be used to explore the temporal sequence of change.

Methodology:

All participants will be assessed using all of the measures described above over a 2 week period. They will then be randomly assigned to one of two groups: Group 1 will be treated using an 8 week course of Mindfulness-Based Cognitive Therapy (MBCT). Group 2 will be treated using an 8 week course of Relaxation Training (RT).This randomization will be carried out by a member of staff at the Ear Institute, who is independent from the clinical part of the trial. He will use a computer programme to complete randomization.

After assessment, patients enter a 'waiting' stage of the trial, during which they receive no intervention for eight weeks. Four weeks into the waiting time, all patients will be sent a letter to confirm the dates and times at which their specific group will take place. On the eighth week, participants will attend the first group session. At this point, prior to commencement of the group, they will complete all of the measures described above for a second time.

All participants will then attend 8 consecutive weeks of group treatment. Throughout this treatment period, at the end of each session, participants will complete two brief measures (the MAAS the TAQ). This is important as it will allow for the temporal sequence of change to be assessed, offering an opportunity to explore the potential mediation effect of mindfulness. At the end of the eighth week, they will again be asked to complete all of the measures for a third time.

All participants will then be invited to attend two further sessions - at 1 and 6 months after treatment completion. At the start of these sessions all participants will be asked to complete all of the measures described above for a fourth and fifth time. These sessions will also provide ongoing support to the participants as they will provide an opportunity to discuss how they are after the groups have finished.

Thus MBCT will be compared to an active control condition (RT) and a passive control condition (wait list control), and RT will also be compared to the passive wait-list control condition. ;


Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02059447
Study type Interventional
Source University College London Hospitals
Contact
Status Completed
Phase N/A
Start date December 2013
Completion date December 2015

See also
  Status Clinical Trial Phase
Recruiting NCT05963542 - Efficacy of Online Acceptance and Commitment Therapy and Sound Therapy for Patients With Tinnitus and Insomnia N/A
Recruiting NCT04987502 - Virtual Reality and Subjective Tinnitus N/A
Recruiting NCT04404439 - Treatment of Tinnitus With Migraine Medications Phase 4
Recruiting NCT05533840 - Establishment and Application of a New Imaging System for Otology Based on Ultra-high Resolution CT
Completed NCT03552302 - Effects of Yoga Exercise on Participates With Tinnitus
Enrolling by invitation NCT02617953 - Objective Diagnosis Method and Efficacy of Repetitive Transcranial Magnetic Stimulation as a Treatment for Tinnitus N/A
Withdrawn NCT01663467 - Efficacy of Internet and Smartphone Application-delivered Tinnitus Retraining Therapy N/A
Completed NCT02974543 - Somatosensory Stimulation to Alleviate Tinnitus N/A
Completed NCT02269839 - A Feasibility Study Assessing the Effectiveness of rTMS in Tinnitus N/A
Completed NCT01929837 - Tinnitus rTMS 2013 N/A
Completed NCT01857661 - The Influence of the Sound Generator Combined With Conventional Amplification for Tinnitus Control: Blind Randomized Clinical Trial N/A
Completed NCT01927991 - Internet-based Self-help for Tinnitus: The Role of Support N/A
Terminated NCT01412918 - Inhibitor Masking Device & Sodium Channel, Voltage Gated, Type IX Alpha Subunit (SCN9) Gene Expression N/A
Completed NCT01480193 - New Therapy for Patients With Severe Tinnitus N/A
Completed NCT00748475 - Countering Stimulus-Induced Alpha-Desynchronization to Treat Tinnitus N/A
Completed NCT00371436 - Progressive Intervention Program for Tinnitus Management N/A
Completed NCT00733044 - Cost-effectiveness of Multidisciplinary Management of Tinnitus N/A
Active, not recruiting NCT05518682 - Assessment of Bimodal Stimulation Device Compliance and Satisfaction in Individuals With Tinnitus N/A
Recruiting NCT05212298 - Effects of Herbal Sleep Formula on Patients With Insomnia and Tinnitus N/A
Completed NCT06025097 - Intra-Tympanic Steroid With PRP Combination in Sensorineural Hearing Loss and Tinnitus. Early Phase 1